Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPulmonologyAetna infant apnea monitor Coverage Update | OpenP…
    Ask Trek AI about this page
    CurrentAetnaPolicy 0003

    Apnea Monitors for Infants

    Customize your policy alerts

    Sign up for Aetna Policy 0003 alerts

    Get alerted when Policy 0003 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity, coverage, coding, and investigational indications for apnea monitors for infants, and specifies clinical criteria and duration of coverage for Aetna members.

    Policy Summary
    PayerAetna
    PolicyApnea Monitors for Infants
    Policy CodePolicy 0003
    Change TypeNo material change
    Effective DateJul 21, 1995
    Last ReviewMar 21, 2023
    Next Review DateJan 11, 2024
    Key ActionObtain and document physician justification to support continuation of monitoring beyond 12 months of age.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    14enumerated medical-necessity indications
    12 modefault infant age cutoff
    43 wk

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    apnea of prematurity cutoff
    3 motypical duration
    E0618, E0619, A4556…key codes cited
    5references

    Coverage Criteria for Infant Apnea Monitors

    Medical Necessity Indications

    Covered when ANY of the following infant-specific clinical indications are present (infants < 12 months unless otherwise specified):

    Covered indications: 1. Diagnosis of pertussis with positive cultures on discharge from acute care facility (monitor up to 1 month post diagnosis).
    Covered indications: 2. Documented apnea accompanied by bradycardia to less than 80 beats per minute; monitor until the infant remains event free for 6 weeks.heart rate < 80 beats/min
    Covered indications: 3. Documented apnea accompanied by marked hypotonia; monitor until the infant remains event free for 6 weeks.
    Covered indications: 4. Documented apnea accompanied by oxygen desaturation (oxygen saturation below 90%), cyanosis or pallor; monitor until the infant remains event free for 6 weeks.SpO2 < 90%
    Covered indications: 5. Documented gastro-esophageal reflux disease (GERD) that results in apnea, bradycardia, or oxygen desaturation; monitor until the infant remains event free for 6 weeks.
    Covered indications: 6. Documented prolonged apnea greater than 20 seconds in duration; monitor until the infant remains event free for 6 weeks.apnea >= 20 seconds
    Covered indications: 7. Infants with an apparent life‑threatening event (ALTE); monitor until the infant remains event free for 6 weeks.

    ALTE defined as combination of apnea, color change, marked change in muscle tone, choking, or gagging.

    Covered indications: 8. Apnea of prematurity (infant < 37 weeks gestational age): continued use is medically necessary until post‑conceptional age > 43 weeks and event free for 6 weeks.post‑conceptional age > 43 weeks

    Post‑conceptional age = gestational age at birth plus age in weeks from birth.

    Covered indications: 9. Infants with bradycardia while on caffeine, theophylline, or similar agents; monitor until event free for 6 weeks off medication.
    Covered indications: 10. Infants with chronic lung disease/bronchopulmonary dysplasia, especially those requiring supplemental oxygen, CPAP, or mechanical ventilation (medical necessity).
    Covered indications: 11. Infants with congenital myasthenic syndromes (medical necessity).
    Covered indications: 12. Infants with neurologic or metabolic disorders affecting respiratory control (medical necessity reviewed on an individual case basis).
    Covered indications: 13. Infants with tracheostomies or anatomic airway abnormalities that make them vulnerable to airway compromise (medical necessity reviewed on an individual case basis).
    Covered indications: 14. Later siblings of infants who died of SIDS: monitor until they are 1 month older than the age at which the earlier sibling died and remain event free.

    Experimental / Investigational

    Not covered — considered experimental/investigational:

    Experimental/Investigational: 1. Infant apnea monitors for indications other than those listed in the medical necessity section (effectiveness not established).
    Experimental/Investigational: 2. Remote infrared sensor (contactless) methods for detection of infant sleep apnea (investigational).

    Continued use of a smart monitor for the purpose of obtaining ongoing pneumograms or sleep studies is not considered medically necessary. If the ordering clinician wishes to continue obtaining pneumograms while the child is on a smart monitor, Aetna will alert the ordering clinician that continued use of the smart monitor for that purpose is not medically necessary. A regular (non-smart) apnea monitor may be considered medically necessary for the duration the clinician requests ongoing studies as specified in the policy.

    This Clinical Policy Bulletin is developed to assist in administering plan benefits and is not a contract and does not constitute an offer of coverage. Coverage for a member is governed by the terms of the member's plan or program benefits; the bulletin provides a general description and does not guarantee coverage.

    Apnea monitors used for indications other than those explicitly listed in the medical necessity section of this policy are considered experimental/investigational because their effectiveness for other indications has not been established and are therefore not medically necessary. The remote infrared sensor method for detection of infant sleep apnea is specifically listed as investigational.

    Coding and Clinical Thresholds

    Covered CPT Codes (when selection criteria met)CPTCovered
    94774Pediatric home apnea monitoring event recording including respiratory rate, pattern and heart rate per 30-day period of time; includes monitor attachment, download of data, physician review, interpretation, and preparation of a report.
    94775Monitor attachment only (includes hook-up, initiation of recording and disconnection).
    94776Monitoring, download of information, receipt of transmission(s) and analyses by computer only.
    94777Physician review, interpretation and preparation of report only.
    Covered HCPCS Codes (when selection criteria met)HCPCSCovered
    A4556Electrodes (e.g., apnea monitor), per pair.
    A4557Lead wires (e.g., apnea monitor), per pair.
    E0618Apnea monitor, without recording feature.
    E0619Apnea monitor, with recording feature.
    Related J-codesHCPCS
    J0706Injection, caffeine citrate, 5 mg.
    J2810Injection, theophylline, per 40 mg.
    Relevant ICD-10 Codes (examples listed)ICD-10
    A37.00 - A37.91Whooping cough.
    G70.2Congenital and developmental myasthenia.
    G93.1Anoxic brain damage, not elsewhere classified.
    I49.5Sick sinus syndrome.
    I49.8Other specified cardiac arrhythmias.
    K21.9Gastro-esophageal reflux disease without esophagitis.
    P07.00 - P07.18 P07.21 - P07.39Disorders of newborn related to short gestation and low birthweight, not elsewhere classified.
    P22.0 - P28.89Respiratory disorders specific to the perinatal period.
    P29.12Neonatal bradycardia.
    P84Other problems with newborn.
    1–10 of 19
    1/2
    Apnea/bradycardia/desaturation alarm thresholds
    Apnea thresholdApnea duration of greater than or equal to 20 seconds triggers alarm
    Bradycardia thresholdHeart rate less than 80 beats per minute triggers alarm
    Desaturation thresholdOxygen saturation below 90% triggers alarm
    Apnea of prematurity age threshold
    DefinitionPost-conceptional age = gestational age at birth plus age in weeks from birth (also referred to as postmenstrual age)
    Apnea of prematurity cutoff

    Provider Actions, Documentation, and Billing Notes

    Documentation Required

    Smart monitor and ongoing studies

    Use of smart monitors and continuation of pneumograms: Because smart monitors can record and transmit detailed data, continued sleep studies and pneumograms are not typically necessary when a smart monitor is used. If the ordering physician requests ongoing pneumograms despite use of a smart monitor, the plan will notify the ordering physician that continued use of a smart monitor for that purpose is not considered medically necessary. Aetna considers a regular (non‑smart) apnea monitor medically necessary for the duration the physician determines ongoing studies are required.

    • Smart monitors — continued pneumograms generally not medically necessary
    • Regular apnea monitor — may be considered medically necessary if physician continues to request ongoing studies
    Note

    Clinical Policy Bulletin is informational

    Informational nature of the Clinical Policy Bulletin: This Clinical Policy Bulletin is provided to assist in administering plan benefits and to summarize medical‑necessity criteria. It is informational only and does not itself guarantee coverage, authorize payment, or substitute for the independent medical judgment of treating providers. Participating providers remain independent practitioners and are responsible for the medical advice and treatment of members.

    Background

    Infant apnea may be central (no respiratory effort), obstructive (chest movement without airflow), or mixed (features of both in the same event). Home apnea monitors typically detect chest movement and heart rate and are configured to alarm for common thresholds such as apnea ≥ 20 seconds, heart rate < 80 beats per minute, or oxygen desaturation events. Contactless remote infrared sensor methods have been investigated but are considered experimental and their effectiveness has not been established.

    Definitions

    Types of infant apnea
    Central apneaNo respiratory effort — chest is still and no airflow through the mouth or nose
    Obstructive apneaChest movement is present but no airflow passes through the mouth or nose, usually due to upper airway obstruction
    Mixed apneaFeatures of both central and obstructive apnea occurring within the same event
    Post-conceptional age
    TermPost-conceptional age
    DefinitionGestational age at birth plus age in weeks from birth (also designated postmenstrual age)
    Usage note

    Revision History

    1995-07-21effective

    Policy became effective.

    2023-03-21last_review

    Policy underwent last review.

    2024-01-11next_reviewLatest

    Next scheduled review date.

    Policy Summary
    PayerAetna
    PolicyApnea Monitors for Infants
    Policy CodePolicy 0003
    Change TypeNo material change
    Effective DateJul 21, 1995
    Last ReviewMar 21, 2023
    Next Review DateJan 11, 2024
    Key ActionObtain and document physician justification to support continuation of monitoring beyond 12 months of age.
    SourceLink
    On This Page
    Coverage Criteria for Infant Apnea MonitorsCoding and Clinical ThresholdsProvider Actions, Documentation, and Billing NotesBackgroundDefinitionsRevision History
    Continued monitoring for apnea of prematurity is considered medically necessary until post-conceptional age exceeds 43 weeks
    Typical gestational criterionApnea of prematurity applies to infants born at less than 37 weeks' gestational age
    • Clinical Policy Bulletin is informational — not a guarantee of coverage or payment
    • Treating providers retain responsibility for clinical decisions
    Documentation Required

    Documentation for continuation beyond 12 months

    Documentation to support continuation of monitoring beyond 12 months: For children older than 12 months, continued apnea monitoring requires physician documentation that justifies ongoing monitoring (for example: persistent alarms, documented recurrent apnea, bradycardia, or hemoglobin/oxygen desaturation). When the policy lists a specified medically necessary duration that extends past 12 months, coverage may continue for that specified duration if adequately documented by the physician.

    • Physician documentation required for monitoring beyond 12 months (e.g., ongoing alarms, documented events, desaturations)
    • Specified medically necessary durations that extend past 12 months remain covered if supported by documentation
    Note

    Clinical Policy Bulletins contain a part and provider responsibilities

    Role and limits of Clinical Policy Bulletins and provider responsibilities: Clinical Policy Bulletins summarize Aetna coverage positions and contain medical‑necessity criteria, coding guidance, and related notes. They do not replace provider clinical judgment, do not themselves authorize services, and do not guarantee coverage. Treating providers are responsible for submitting appropriate documentation (clinical records, testing results, and justification for continued monitoring) to support coverage decisions and any prior authorization requests determined by the plan.

    • CPBs contain medical‑necessity criteria, coding guidance, and billing notes
    • CPBs are not coverage guarantees or authorizations
    • Providers must submit clinical documentation and supporting records for coverage review or prior authorization
    Used to determine end of medically necessary monitoring for apnea of prematurity (see 43-week cutoff)
    Apparent Life‑Threatening Event (ALTE)
    ALTE definitionAn apparent life‑threatening event (ALTE) is an episode characterized by some combination of apnea (central or occasionally obstructive), color change (usually cyanotic or pallid), marked change in muscle tone (usually marked limpness), choking, or gagging
    Monitoring durationIf monitored due to ALTE, use of an apnea monitor is considered medically necessary until the infant remains event free for 6 weeks
    ContextALTE is listed among indications that make apnea monitoring medically necessary for infants under this policy
    Additional definitions / policy notes
    Smart monitor pneumogramsBecause of smart monitor capabilities, continuing sleep studies and pneumograms are not typically necessary; continued pneumograms while on a smart monitor are not considered medically necessary
    Typical durationInfant apnea monitors are usually considered medically necessary for approximately 3 months except as specified for certain indications
    Monitoring beyond 12 monthsContinuation of monitoring beyond 12 months requires physician documentation (e.g., continued alarms or documented events)